HEADER HYDROLASE 25-JAN-07 2JF4 TITLE FAMILY 37 TREHALASE FROM ESCHERICHIA COLI IN COMPLEX WITH TITLE 2 VALIDOXYLAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PERIPLASMIC TREHALASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 31-565; COMPND 5 SYNONYM: TREHALASE, ALPHA-ALPHA-TREHALASE, COMPND 6 ALPHA-ALPHA-TREHALOSE GLUCOHYDROLASE; COMPND 7 EC: 3.2.1.28; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS FAMILY 37, HYDROLASE, INHIBITOR, TREHALASE, GLYCOSIDE KEYWDS 2 HYDROLASE, PERIPLASMIC, GLYCOSIDASE, VALIDOXYLAMINE EXPDTA X-RAY DIFFRACTION AUTHOR R.P.GIBSON,T.M.GLOSTER,S.ROBERTS,R.A.J.WARREN, AUTHOR 2 I.STORCH DE GRACIA,A.GARCIA,J.L.CHIARA,G.J.DAVIES REVDAT 2 24-FEB-09 2JF4 1 VERSN REVDAT 1 13-FEB-07 2JF4 0 JRNL AUTH R.P.GIBSON,T.M.GLOSTER,S.ROBERTS,R.A.J.WARREN, JRNL AUTH 2 I.STORCH DE GRACIA,A.GARCIA,J.L.CHIARA,G.J.DAVIES JRNL TITL MOLECULAR BASIS FOR TREHALASE INHIBITION REVEALED JRNL TITL 2 BY THE STRUCTURE OF TREHALASE IN COMPLEX WITH JRNL TITL 3 POTENT INHIBITORS. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 46 4115 2007 JRNL REFN ISSN 1433-7851 JRNL PMID 17455176 JRNL DOI 10.1002/ANIE.200604825 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 25985 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1384 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1891 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1730 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.2540 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3907 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 296 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.79000 REMARK 3 B22 (A**2) : 1.29000 REMARK 3 B33 (A**2) : -0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.259 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.122 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.672 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.920 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4161 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5682 ; 1.290 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 5.080 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 212 ;36.102 ;24.623 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 657 ;14.724 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;13.517 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 599 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3273 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1892 ; 0.194 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2841 ; 0.301 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 258 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 19 ; 0.224 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 17 ; 0.135 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2590 ; 1.144 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4050 ; 1.297 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1846 ; 2.134 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1625 ; 3.130 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. NO ELECTRON DENSITY CAN BE OBSERVED FOR THE REMARK 3 CHAIN BETWEEN 101 AND 113. REMARK 4 REMARK 4 2JF4 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-JAN-07. REMARK 100 THE PDBE ID CODE IS EBI-31240. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) OR REMARK 200 SI(311) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27378 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.2 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 MG/ML PROTEIN. 25% PEG3350 REMARK 280 AND 0.1 M BIS-TRIS HCL, PH 6.5. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.69950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.58700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.34800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.58700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.69950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.34800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 31 REMARK 465 GLU A 32 REMARK 465 THR A 33 REMARK 465 PRO A 34 REMARK 465 VAL A 35 REMARK 465 THR A 36 REMARK 465 LYS A 102 REMARK 465 GLU A 103 REMARK 465 GLY A 104 REMARK 465 GLU A 105 REMARK 465 LYS A 106 REMARK 465 TYR A 107 REMARK 465 VAL A 108 REMARK 465 PRO A 109 REMARK 465 PRO A 110 REMARK 465 GLU A 111 REMARK 465 GLY A 112 REMARK 465 THR A 548 REMARK 465 VAL A 549 REMARK 465 LYS A 550 REMARK 465 SER A 551 REMARK 465 ALA A 552 REMARK 465 THR A 553 REMARK 465 THR A 554 REMARK 465 GLN A 555 REMARK 465 PRO A 556 REMARK 465 SER A 557 REMARK 465 THR A 558 REMARK 465 LYS A 559 REMARK 465 GLU A 560 REMARK 465 ALA A 561 REMARK 465 GLN A 562 REMARK 465 PRO A 563 REMARK 465 THR A 564 REMARK 465 PRO A 565 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 134 CG CD OE1 OE2 REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 176 CD CE NZ REMARK 470 LYS A 535 CB CG CD CE NZ REMARK 470 GLU A 536 CB CG CD OE1 OE2 REMARK 470 GLN A 537 CB CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 158 -70.49 -65.54 REMARK 500 SER A 206 -142.70 -115.72 REMARK 500 LYS A 255 -117.87 51.99 REMARK 500 SER A 280 44.88 -142.90 REMARK 500 ARG A 328 59.62 -144.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 TRP A 159 25.0 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VDM A1548 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FIRST 30 RESIDUES CORRESPOND TO A SIGNAL PEPTIDE THAT REMARK 999 IS PREDICTED TO HAVE CLEAVED DURING EXPRESSION OF THE REMARK 999 PROTEIN. DBREF 2JF4 A 31 565 UNP P13482 TREA_ECOLI 31 565 SEQRES 1 A 535 GLU GLU THR PRO VAL THR PRO GLN PRO PRO ASP ILE LEU SEQRES 2 A 535 LEU GLY PRO LEU PHE ASN ASP VAL GLN ASN ALA LYS LEU SEQRES 3 A 535 PHE PRO ASP GLN LYS THR PHE ALA ASP ALA VAL PRO ASN SEQRES 4 A 535 SER ASP PRO LEU MSE ILE LEU ALA ASP TYR ARG MSE GLN SEQRES 5 A 535 GLN ASN GLN SER GLY PHE ASP LEU ARG HIS PHE VAL ASN SEQRES 6 A 535 VAL ASN PHE THR LEU PRO LYS GLU GLY GLU LYS TYR VAL SEQRES 7 A 535 PRO PRO GLU GLY GLN SER LEU ARG GLU HIS ILE ASP GLY SEQRES 8 A 535 LEU TRP PRO VAL LEU THR ARG SER THR GLU ASN THR GLU SEQRES 9 A 535 LYS TRP ASP SER LEU LEU PRO LEU PRO GLU PRO TYR VAL SEQRES 10 A 535 VAL PRO GLY GLY ARG PHE ARG GLU VAL TYR TYR TRP ASP SEQRES 11 A 535 SER TYR PHE THR MSE LEU GLY LEU ALA GLU SER GLY HIS SEQRES 12 A 535 TRP ASP LYS VAL ALA ASP MSE VAL ALA ASN PHE ALA HIS SEQRES 13 A 535 GLU ILE ASP THR TYR GLY HIS ILE PRO ASN GLY ASN ARG SEQRES 14 A 535 SER TYR TYR LEU SER ARG SER GLN PRO PRO PHE PHE ALA SEQRES 15 A 535 LEU MSE VAL GLU LEU LEU ALA GLN HIS GLU GLY ASP ALA SEQRES 16 A 535 ALA LEU LYS GLN TYR LEU PRO GLN MSE GLN LYS GLU TYR SEQRES 17 A 535 ALA TYR TRP MSE ASP GLY VAL GLU ASN LEU GLN ALA GLY SEQRES 18 A 535 GLN GLN GLU LYS ARG VAL VAL LYS LEU GLN ASP GLY THR SEQRES 19 A 535 LEU LEU ASN ARG TYR TRP ASP ASP ARG ASP THR PRO ARG SEQRES 20 A 535 PRO GLU SER TRP VAL GLU ASP ILE ALA THR ALA LYS SER SEQRES 21 A 535 ASN PRO ASN ARG PRO ALA THR GLU ILE TYR ARG ASP LEU SEQRES 22 A 535 ARG SER ALA ALA ALA SER GLY TRP ASP PHE SER SER ARG SEQRES 23 A 535 TRP MSE ASP ASN PRO GLN GLN LEU ASN THR LEU ARG THR SEQRES 24 A 535 THR SER ILE VAL PRO VAL ASP LEU ASN SER LEU MSE PHE SEQRES 25 A 535 LYS MSE GLU LYS ILE LEU ALA ARG ALA SER LYS ALA ALA SEQRES 26 A 535 GLY ASP ASN ALA MSE ALA ASN GLN TYR GLU THR LEU ALA SEQRES 27 A 535 ASN ALA ARG GLN LYS GLY ILE GLU LYS TYR LEU TRP ASN SEQRES 28 A 535 ASP GLN GLN GLY TRP TYR ALA ASP TYR ASP LEU LYS SER SEQRES 29 A 535 HIS LYS VAL ARG ASN GLN LEU THR ALA ALA ALA LEU PHE SEQRES 30 A 535 PRO LEU TYR VAL ASN ALA ALA ALA LYS ASP ARG ALA ASN SEQRES 31 A 535 LYS MSE ALA THR ALA THR LYS THR HIS LEU LEU GLN PRO SEQRES 32 A 535 GLY GLY LEU ASN THR THR SER VAL LYS SER GLY GLN GLN SEQRES 33 A 535 TRP ASP ALA PRO ASN GLY TRP ALA PRO LEU GLN TRP VAL SEQRES 34 A 535 ALA THR GLU GLY LEU GLN ASN TYR GLY GLN LYS GLU VAL SEQRES 35 A 535 ALA MSE ASP ILE SER TRP HIS PHE LEU THR ASN VAL GLN SEQRES 36 A 535 HIS THR TYR ASP ARG GLU LYS LYS LEU VAL GLU LYS TYR SEQRES 37 A 535 ASP VAL SER THR THR GLY THR GLY GLY GLY GLY GLY GLU SEQRES 38 A 535 TYR PRO LEU GLN ASP GLY PHE GLY TRP THR ASN GLY VAL SEQRES 39 A 535 THR LEU LYS MSE LEU ASP LEU ILE CYS PRO LYS GLU GLN SEQRES 40 A 535 PRO CYS ASP ASN VAL PRO ALA THR ARG PRO THR VAL LYS SEQRES 41 A 535 SER ALA THR THR GLN PRO SER THR LYS GLU ALA GLN PRO SEQRES 42 A 535 THR PRO MODRES 2JF4 MSE A 74 MET SELENOMETHIONINE MODRES 2JF4 MSE A 81 MET SELENOMETHIONINE MODRES 2JF4 MSE A 165 MET SELENOMETHIONINE MODRES 2JF4 MSE A 180 MET SELENOMETHIONINE MODRES 2JF4 MSE A 214 MET SELENOMETHIONINE MODRES 2JF4 MSE A 234 MET SELENOMETHIONINE MODRES 2JF4 MSE A 242 MET SELENOMETHIONINE MODRES 2JF4 MSE A 318 MET SELENOMETHIONINE MODRES 2JF4 MSE A 341 MET SELENOMETHIONINE MODRES 2JF4 MSE A 344 MET SELENOMETHIONINE MODRES 2JF4 MSE A 360 MET SELENOMETHIONINE MODRES 2JF4 MSE A 422 MET SELENOMETHIONINE MODRES 2JF4 MSE A 474 MET SELENOMETHIONINE MODRES 2JF4 MSE A 528 MET SELENOMETHIONINE HET MSE A 74 8 HET MSE A 81 8 HET MSE A 165 8 HET MSE A 180 8 HET MSE A 214 8 HET MSE A 234 8 HET MSE A 242 8 HET MSE A 318 8 HET MSE A 341 8 HET MSE A 344 8 HET MSE A 360 8 HET MSE A 422 8 HET MSE A 474 8 HET MSE A 528 8 HET VDM A1548 23 HETNAM MSE SELENOMETHIONINE HETNAM VDM (1S,2S,3R,6S)-4-(HYDROXYMETHYL)-6-{[(1S,2S, HETNAM 2 VDM 3S,4R,5R)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL) HETNAM 3 VDM CYCLOHEXYL]AMINO}CYCLOHEX-4-ENE-1,2,3-TRIOL HETSYN VDM VALIDOXYLAMINE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 2 VDM C14 H25 N O8 FORMUL 3 HOH *296(H2 O1) HELIX 1 1 PRO A 39 LEU A 44 1 6 HELIX 2 2 LEU A 44 LYS A 55 1 12 HELIX 3 3 GLN A 60 ASP A 65 1 6 HELIX 4 4 ASP A 71 GLN A 83 1 13 HELIX 5 5 ASP A 89 ASN A 97 1 9 HELIX 6 6 SER A 114 LEU A 126 1 13 HELIX 7 7 TYR A 157 SER A 171 1 15 HELIX 8 8 HIS A 173 GLY A 192 1 20 HELIX 9 9 SER A 200 LEU A 203 5 4 HELIX 10 10 PHE A 210 GLY A 223 1 14 HELIX 11 11 GLY A 223 TYR A 230 1 8 HELIX 12 12 TYR A 230 MSE A 242 1 13 HELIX 13 13 ARG A 277 GLU A 279 5 3 HELIX 14 14 SER A 280 SER A 290 1 11 HELIX 15 15 PRO A 295 SER A 309 1 15 HELIX 16 16 SER A 314 TRP A 317 5 4 HELIX 17 17 GLN A 323 THR A 326 5 4 HELIX 18 18 ARG A 328 THR A 330 5 3 HELIX 19 19 PRO A 334 GLY A 356 1 23 HELIX 20 20 ASP A 357 LEU A 379 1 23 HELIX 21 21 ALA A 403 ALA A 405 5 3 HELIX 22 22 LEU A 406 VAL A 411 1 6 HELIX 23 23 ALA A 415 LEU A 430 1 16 HELIX 24 24 TRP A 453 ASN A 466 1 14 HELIX 25 25 GLN A 469 LYS A 492 1 24 HELIX 26 26 PHE A 518 CYS A 533 1 16 SHEET 1 AA 2 VAL A 67 PRO A 68 0 SHEET 2 AA 2 PHE A 98 THR A 99 -1 O THR A 99 N VAL A 67 SHEET 1 AB 2 THR A 127 ARG A 128 0 SHEET 2 AB 2 TYR A 146 VAL A 147 -1 O TYR A 146 N ARG A 128 SHEET 1 AC 3 GLN A 252 GLU A 254 0 SHEET 2 AC 3 VAL A 257 LYS A 259 -1 O VAL A 257 N GLU A 254 SHEET 3 AC 3 LEU A 265 ASN A 267 -1 O LEU A 266 N VAL A 258 SHEET 1 AD 3 ILE A 332 VAL A 333 0 SHEET 2 AD 3 TYR A 390 ASP A 391 -1 O TYR A 390 N VAL A 333 SHEET 3 AD 3 LYS A 396 VAL A 397 -1 O LYS A 396 N ASP A 391 SHEET 1 AE 2 TRP A 380 ASN A 381 0 SHEET 2 AE 2 TRP A 386 TYR A 387 -1 O TRP A 386 N ASN A 381 SHEET 1 AF 2 LEU A 431 GLN A 432 0 SHEET 2 AF 2 GLY A 435 LEU A 436 -1 O GLY A 435 N GLN A 432 SHEET 1 AG 2 ASN A 451 GLY A 452 0 SHEET 2 AG 2 TYR A 498 ASP A 499 -1 O TYR A 498 N GLY A 452 SHEET 1 AH 2 LEU A 494 VAL A 495 0 SHEET 2 AH 2 ASP A 516 GLY A 517 -1 O GLY A 517 N LEU A 494 SSBOND 1 CYS A 533 CYS A 539 1555 1555 2.58 SSBOND 2 CYS A 533 CYS A 539 1555 1555 2.06 LINK C LEU A 73 N MSE A 74 1555 1555 1.32 LINK C MSE A 74 N ILE A 75 1555 1555 1.33 LINK C ARG A 80 N MSE A 81 1555 1555 1.33 LINK C MSE A 81 N GLN A 82 1555 1555 1.33 LINK C THR A 164 N MSE A 165 1555 1555 1.33 LINK C MSE A 165 N LEU A 166 1555 1555 1.33 LINK C ASP A 179 N MSE A 180 1555 1555 1.33 LINK C MSE A 180 N VAL A 181 1555 1555 1.33 LINK C LEU A 213 N MSE A 214 1555 1555 1.34 LINK C MSE A 214 N VAL A 215 1555 1555 1.34 LINK C GLN A 233 N MSE A 234 1555 1555 1.34 LINK C MSE A 234 N GLN A 235 1555 1555 1.33 LINK C TRP A 241 N MSE A 242 1555 1555 1.34 LINK C MSE A 242 N ASP A 243 1555 1555 1.33 LINK C TRP A 317 N MSE A 318 1555 1555 1.34 LINK C MSE A 318 N ASP A 319 1555 1555 1.33 LINK C LEU A 340 N MSE A 341 1555 1555 1.34 LINK C MSE A 341 N PHE A 342 1555 1555 1.33 LINK C LYS A 343 N MSE A 344 1555 1555 1.33 LINK C MSE A 344 N GLU A 345 1555 1555 1.33 LINK C ALA A 359 N MSE A 360 1555 1555 1.33 LINK C MSE A 360 N ALA A 361 1555 1555 1.33 LINK C LYS A 421 N MSE A 422 1555 1555 1.33 LINK C MSE A 422 N ALA A 423 1555 1555 1.33 LINK C ALA A 473 N MSE A 474 1555 1555 1.34 LINK C MSE A 474 N ASP A 475 1555 1555 1.33 LINK C LYS A 527 N MSE A 528 1555 1555 1.34 LINK C MSE A 528 N LEU A 529 1555 1555 1.33 CISPEP 1 ASP A 312 PHE A 313 0 0.25 CISPEP 2 ALA A 449 PRO A 450 0 -2.73 CISPEP 3 GLY A 517 PHE A 518 0 -4.24 SITE 1 AC1 23 ARG A 152 PHE A 153 TYR A 157 TRP A 159 SITE 2 AC1 23 ASP A 160 ASN A 196 TYR A 202 ARG A 205 SITE 3 AC1 23 GLN A 207 ARG A 277 GLU A 279 SER A 280 SITE 4 AC1 23 ALA A 307 GLY A 310 ASP A 312 GLN A 446 SITE 5 AC1 23 TRP A 447 GLU A 511 TYR A 512 PHE A 518 SITE 6 AC1 23 TRP A 520 HOH A2178 HOH A2263 CRYST1 49.399 102.696 103.174 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020243 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009737 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009692 0.00000